330 
(9) Tobacco addiction and exposure to other 
lung cancer carcinogens such as Agent Orange and 
other herbicides and battlefield emissions are serious 
problems among military personnel and war vet-
erans. 
(10) Significant and rapid improvements in 
lung cancer mortality can be expected through great-
er use and access to lung cancer screening tests for 
at-risk individuals. 
(11) Additional strategies are necessary to fur-
ther enhance the existing tests and therapies avail-
able to diagnose and treat lung cancer in the future. 
(12) The August 2001 Report of the Lung 
Cancer Progress Review Group of the National Can-
cer Institute stated that funding for lung cancer re-
search was ‘‘far below the levels characterized for 
other common malignancies and far out of propor-
tion to its massive health impact’’. 
(13) The Report of the Lung Cancer Progress 
Review Group identified as its ‘‘highest priority’’ the 
creation of integrated, multidisciplinary, multi-insti-
tutional research consortia organized around the 
problem of lung cancer rather than around specific 
research disciplines. 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00330
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
331 
(14) The United States must enhance its re-
sponse to the issues raised in the Report of the 
Lung Cancer Progress Review Group, and this can 
be accomplished through the establishment of a co-
ordinated effort designed to reduce the lung cancer 
mortality rate by 50 percent by 2015 and targeted 
funding to support this coordinated effort. 
SEC. 543. SENSE OF CONGRESS CONCERNING INVESTMENT 
IN LUNG CANCER RESEARCH. 
It is the sense of the Congress that— 
(1) lung cancer mortality reduction should be 
made a national public health priority; and 
(2) a comprehensive mortality reduction pro-
gram coordinated by the Secretary of Health and 
Human Services is justified and necessary to ade-
quately address and reduce lung cancer mortality. 
SEC. 544. LUNG CANCER MORTALITY REDUCTION PRO-
GRAM. 
(a) IN GENERAL.—Subpart 1 of part C of title IV 
of the Public Health Service Act (42 U.S.C. 285 et seq.) 
is amended by adding at the end the following: 
‘‘SEC. 417G. LUNG CANCER MORTALITY REDUCTION PRO-
GRAM. 
‘‘(a) IN GENERAL.—Not later than 6 months after 
the date of the enactment of this section, the Secretary, 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00331
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
332 
in consultation with the Secretary of Defense, the Sec-
retary of Veterans Affairs, the Director of the National 
Institutes of Health, the Director of the Centers for Dis-
ease Control and Prevention, the Commissioner of Food 
and Drugs, the Administrator of the Centers for Medicare 
& Medicaid Services, the Director of the National Center 
on Minority Health and Health Disparities, and other 
members of the Lung Cancer Advisory Board established 
under section 546 of the Lung Cancer Mortality Reduc-
tion Act of 2009, shall implement a comprehensive pro-
gram, to be known as the Lung Cancer Mortality Reduc-
tion Program, to achieve a reduction of at least 25 percent 
in the mortality rate of lung cancer by 2015. 
‘‘(b) REQUIREMENTS.—The Program shall include at 
least the following: 
‘‘(1) With respect to the National Institutes of 
Health— 
‘‘(A) a strategic review and prioritization 
by the National Cancer Institute of research 
grants to achieve the goal of the Lung Cancer 
Mortality Reduction Program in reducing lung 
cancer mortality; 
‘‘(B) the provision of funds to enable the 
Airway Biology and Disease Branch of the Na-
tional Heart, Lung, and Blood Institute to ex-
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00332
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
333 
pand its research programs to include pre-
dispositions to lung cancer, the interrelationship 
between lung cancer and other pulmonary and 
cardiac disease, and the diagnosis and treat-
ment of these interrelationships; 
‘‘(C) the provision of funds to enable the 
National Institute of Biomedical Imaging and 
Bioengineering to expedite the development of 
computer assisted diagnostic, surgical, treat-
ment, and drug testing innovations to reduce 
lung cancer mortality, such as through expan-
sion of the Institute’s Quantum Grant Program 
and Image-Guided Interventions programs; and 
‘‘(D) the provision of funds to enable the 
National Institute of Environmental Health 
Sciences to implement research programs rel-
ative to the lung cancer incidence. 
‘‘(2) With respect to the Food and Drug Ad-
ministration— 
‘‘(A) activities under section 529 of the 
Federal Food, Drug, and Cosmetic Act; and 
‘‘(B) activities under section 561 of the 
Federal Food, Drug, and Cosmetic Act to ex-
pand access to investigational drugs and devices 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00333
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
334 
for the diagnosis, monitoring, or treatment of 
lung cancer. 
‘‘(3) With respect to the Centers for Disease 
Control and Prevention, the establishment of an 
early disease research and management program 
under section 1511. 
‘‘(4) With respect to the Agency for Healthcare 
Research and Quality, the conduct of a biannual re-
view of lung cancer screening, diagnostic, and treat-
ment protocols, and the issuance of updated guide-
lines. 
‘‘(5) The cooperation and coordination of all 
minority and health disparity programs within the 
Department of Health and Human Services to en-
sure that all aspects of the Lung Cancer Mortality 
Reduction Program under this section adequately 
address the burden of lung cancer on minority and 
rural populations. 
‘‘(6) The cooperation and coordination of all to-
bacco control and cessation programs within agen-
cies of the Department of Health and Human Serv-
ices to achieve the goals of the Lung Cancer Mor-
tality Reduction Program under this section with 
particular emphasis on the coordination of drug and 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00334
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
335 
other cessation treatments with early detection pro-
tocols.’’. 
(b) FEDERAL FOOD, DRUG, AND COSMETIC ACT.— 
Subchapter B of chapter V of the Federal Food, Drug, 
and Cosmetic Act (21 U.S.C. 360aaa et seq.) is amended 
by adding at the end the following: 
‘‘DRUGS RELATING TO LUNG CANCER 
‘‘SEC. 529. (a) IN GENERAL.—The provisions of this 
subchapter shall apply to a drug described in subsection 
(b) to the same extent and in the same manner as such 
provisions apply to a drug for a rare disease or condition. 
‘‘(b) QUALIFIED DRUGS.—A drug described in this 
subsection is— 
‘‘(1) a chemoprevention drug for precancerous 
conditions of the lung; 
‘‘(2) a drug for a targeted therapeutic treat-
ments, including any vaccine for, lung cancer; and 
‘‘(3) a drug to curtail or prevent nicotine addic-
tion. 
‘‘(c) BOARD.—The Board established under section 
546 of the Lung Cancer Mortality Reduction Act of 2009 
shall monitor the program implemented under this sec-
tion.’’. 
(c) ACCESS TO UNAPPROVED THERAPIES.—Section 
561(e) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360bbb(e)) is amended by inserting before the pe-
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00335
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
336 
riod the following: ‘‘and shall include expanding access to 
drugs under section 529, with substantial consideration 
being given to whether the totality of information available 
to the Secretary regarding the safety and effectiveness of 
an investigational drug, as compared to the risk of mor-
bidity and death from the disease, indicates that a patient 
may obtain more benefit than risk if treated with the 
drug’’. 
(d) CDC.—Title XV of the Public Health Service Act 
(42 U.S.C. 300k et seq.) is amended by adding at the end 
the following: 
‘‘SEC. 1511. EARLY DISEASE RESEARCH AND MANAGEMENT 
PROGRAM. 
‘‘The Secretary shall establish and implement an 
early disease research and management program targeted 
at the high incidence and mortality rates of lung cancer 
among minority and low-income populations.’’. 
SEC. 545. DEPARTMENT OF DEFENSE AND THE DEPART-
MENT OF VETERANS AFFAIRS. 
The Secretary of Defense and the Secretary of Vet-
erans Affairs shall coordinate with the Secretary of Health 
and Human Services— 
(1) in the development of the Lung Cancer 
Mortality Reduction Program under section 417G; 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00336
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
337 
(2) in the implementation within the Depart-
ment of Defense and the Department of Veterans 
Affairs of an early detection and disease manage-
ment research program for military personnel and 
veterans whose smoking history and exposure to car-
cinogens during active duty service has increased 
their risk for lung cancer; and 
(3) in the implementation of coordinated care 
programs for military personnel and veterans diag-
nosed with lung cancer. 
SEC. 546. LUNG CANCER ADVISORY BOARD. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services shall convene a Lung Cancer Advisory 
Board (referred to in this section as the ‘‘Board’’)— 
(1) to monitor the programs established under 
this chapter (and the amendments made by this 
chapter); and 
(2) to provide annual reports to the Congress 
concerning benchmarks, expenditures, lung cancer 
statistics, and the public health impact of such pro-
grams. 
(b) COMPOSITION.—The Board shall be composed 
of— 
(1) the Secretary of Health and Human Serv-
ices; 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00337
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
338 
(2) the Secretary of Defense; 
(3) the Secretary of Veterans Affairs; and 
(4) two representatives each from the fields of 
clinical medicine focused on lung cancer, lung cancer 
research, imaging, drug development, and lung can-
cer advocacy, to be appointed by the Secretary of 
Health and Human Services. 
SEC. 547. AUTHORIZATION OF APPROPRIATIONS. 
(a) IN GENERAL.—To carry out this chapter (and the 
amendments made by this chapter), there are authorized 
to be appropriated such sums as may be necessary for 
each of fiscal years 2010 through 2014. 
(b) LUNG CANCER MORTALITY REDUCTION PRO-
GRAM.—Of the amounts authorized to be appropriated by 
subsection (a), there are authorized to be appropriated— 
(1) $25,000,000 for fiscal year 2010, and such 
sums as may be necessary for each of fiscal years 
2011 through 2014, for the activities described in 
section 417G(b)(1)(B) of the Public Health Service 
Act, as added by section 544(a); 
(2) $25,000,000 for fiscal year 2010, and such 
sums as may be necessary for each of fiscal years 
2011 through 2014, for the activities described in 
section 417G(b)(1)(C) of such Act; 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00338
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
339 
(3) $10,000,000 for fiscal year 2010, and such 
sums as may be necessary for each of fiscal years 
2011 through 2014, for the activities described in 
section 417G(b)(1)(D) of such Act; and 
(4) $15,000,000 for fiscal year 2010, and such 
sums as may be necessary for each of fiscal years 
2011 through 2014, for the activities described in 
section 417G(b)(3) of such Act. 
TITLE 
VI—ELIMINATING 
DIS-
PARITIES IN DIABETES PRE-
VENTION ACCESS AND CARE 
ACT 
Subtitle A—NATIONAL 
INSTITUTES OF HEALTH 
SEC. 611. RESEARCH, TREATMENT, AND EDUCATION. 
(a) IN GENERAL.—Subpart 3 of part C of title IV 
of the Public Health Service Act (42 U.S.C. 285c et seq.) 
is amended by adding at the end the following new section: 
‘‘SEC. 434B. DIABETES IN MINORITY POPULATIONS. 
‘‘(a) IN GENERAL.—The Director of the National In-
stitutes of Health shall expand, intensify, and support on-
going research and other activities with respect to pre-dia-
betes and diabetes, particularly type 2, in minority popu-
lations, including research to identify clinical, socio-
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00339
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
340 
economic, geographical, cultural, and organizational fac-
tors that contribute to type 2 diabetes in such populations. 
‘‘(b) CERTAIN ACTIVITIES.—Activities under sub-
section (a) regarding type 2 diabetes in minority popu-
lations shall include the following: 
‘‘(1) Continue research on behavior and obesity, 
including research through the obesity research cen-
ter that is sponsored by the National Institutes of 
Health. 
‘‘(2) Research on environmental factors that 
may contribute to the increase in type 2 diabetes. 
‘‘(3) Support for new methods to identify envi-
ronmental triggers and genetic interactions that lead 
to the development of type 2 diabetes in minority 
newborns. Such research should follow the newborns 
through puberty, an increasingly high-risk period for 
developing type 2 diabetes. 
‘‘(4) Research to identify genes that predispose 
individuals to the onset of developing type 1 and 
type 2 diabetes and to the development of complica-
tions. 
‘‘(5) Research to prevent complications in indi-
viduals who have already developed diabetes, such as 
research that attempts to identify the genes that 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00340
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
341 
predispose individuals with diabetes to the develop-
ment of complications. 
‘‘(6) Research methods and alternative thera-
pies to control blood glucose. 
‘‘(7) Support of ongoing research efforts exam-
ining the level of glycemia at which adverse out-
comes develop during pregnancy and to address the 
many clinical issues associated with minority moth-
ers and fetuses during diabetic and gestational dia-
betic pregnancies. 
‘‘(c) EDUCATION.—The Director of the National In-
stitutes of Health shall— 
‘‘(1) through the National Center on Minority 
Health and Health Disparities and the National Di-
abetes Education Program— 
‘‘(A) make grants to programs funded 
under section 485F (relating to centers of ex-
cellence) for the purpose of establishing a men-
toring program for health care professionals to 
be more involved in weight counseling, obesity 
research, and nutrition; and 
‘‘(B) provide for the participation of mi-
nority health professionals in diabetes-focused 
research programs; and 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00341
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
342 
‘‘(2) make grants for programs to establish a 
pipeline from high school to professional school that 
will increase minority representation in diabetes-fo-
cused health fields by expanding Minority Access to 
Research Careers (MARC) program internships and 
mentoring opportunities for recruitment. 
‘‘(d) DEFINITION.—For purposes of this section, the 
term ‘minority population’ means a racial and ethnic mi-
nority group, as defined in section 1707. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated such sums as are necessary for fiscal 
year 2010 and each subsequent fiscal year.’’. 
(b) DIABETES MELLITUS INTERAGENCY COORDI-
NATING COMMITTEE.—Section 429 of the Public Health 
Service Act (42 U.S.C. 285c–3) is amended by adding at 
the end the following new subsection: 
‘‘(c)(1) In each annual report prepared by the Diabe-
tes Mellitus Interagency Coordinating Committee, the 
Committee shall include an assessment of the Federal ac-
tivities and programs related to diabetes in minority popu-
lations. Such assessment shall— 
‘‘(A) compile the current activities of all 
current Federal health programs to allow for 
the assessment of their adequacy as a systemic 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00342
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
343 
method of addressing the impact of diabetes 
mellitus on minority populations; 
‘‘(B) develop strategic planning activities 
to develop an effective and comprehensive Fed-
eral plan to address diabetes mellitus within mi-
nority populations which will involve all appro-
priate Federal health programs and shall— 
‘‘(i) include steps to address issues in-
cluding type 1 and type 2 diabetes in chil-
dren and the disproportionate impact of di-
abetes mellitus on minority populations; 
and 
‘‘(ii) remain consistent with the pro-
grams and activities identified in section 
399O, as well as remaining consistent with 
the intent of the Eliminating Disparities in 
Diabetes Prevention Access and Care Act 
of 2009; and 
‘‘(C) assess the implementation of such a 
plan throughout Federal health programs. 
‘‘(2) For the purposes of this subsection, the 
term ‘minority population’ means a racial and ethnic 
minority group, as defined in section 1707. 
‘‘(3) For the purpose of carrying out this sub-
section, there are authorized to be appropriated such 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00343
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
344 
sums as are necessary for fiscal year 2010 and each 
subsequent fiscal year.’’. 
Subtitle B—CENTERS FOR DIS-
EASE CONTROL AND PREVEN-
TION 
SEC. 621. RESEARCH, EDUCATION, AND OTHER ACTIVITIES. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.) is amended by inserting after sec-
tion 317T the following section: 
‘‘SEC. 317U. DIABETES IN MINORITY POPULATIONS. 
‘‘(a) RESEARCH AND OTHER ACTIVITIES.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall conduct and support 
research and other activities with respect to diabetes 
in minority populations. 
‘‘(2) CERTAIN
ACTIVITIES.—Activities under 
paragraph (1) regarding diabetes in minority popu-
lations shall include the following: 
‘‘(A) Expanding the National Diabetes 
Laboratory capacity for translational research 
and 
the 
identification 
of 
genetic 
and 
immunological risk factors associated with dia-
betes. 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00344
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
345 
‘‘(B) Enhancing the National Health and 
Nutrition Examination Survey to include risk 
factors for type 2 diabetes and pre-diabetes 
with emphasis on eating and dietary habits, and 
focus, including cultural and socioeconomic fac-
tors, on Hispanic-American, African-American, 
American Indian and Alaskan Native, and 
Asian-American, Native Hawaiian and other 
Pacific Islander communities. 
‘‘(C) Further enhancing the National 
Health and Nutrition Examination Survey by 
over-sampling Asian-American, Native Hawai-
ian, and Other Pacific Islanders in appropriate 
geographic areas to better determine the preva-
lence of diabetes in such populations as well as 
to improve the data collection of diabetes pene-
tration disaggregated into major ethnic groups 
within such populations. 
‘‘(D) Within the Division of Diabetes 
Translation, providing for prevention research 
to better understand how to influence health 
care systems changes to improve quality of care 
being delivered to such populations, and within 
the Division of Diabetes Translation, carrying 
out model demonstration projects to design, im-
VerDate Nov 24 2008 
04:52 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00345
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
346 
plement, and evaluate effective diabetes preven-
tion and control intervention for such popu-
lations. 
‘‘(E) Through the Division of Diabetes 
Translation, carrying out culturally appropriate 
community-based interventions designed to ad-
dress issues and problems experienced by such 
populations. 
‘‘(F) Conducting applied research within 
the Division of Diabetes Translation to reduce 
health disparities within such populations with 
diabetes. 
‘‘(G) Conducting applied research on pri-
mary prevention within the Division of Diabetes 
Translation to specifically focus on such popu-
lations with pre-diabetes. 
‘‘(b) EDUCATION.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall direct the Division of 
Diabetes Translation to conduct and support pro-
grams to educate the public on the causes and ef-
fects of diabetes in minority populations. 
‘‘(2) CERTAIN
ACTIVITIES.—Programs under 
paragraph (1) regarding education on diabetes in 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00346
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
347 
minority populations shall include carrying out pub-
lic awareness campaigns directed toward such popu-
lations to aggressively emphasize the importance and 
impact of physical activity and diet in regard to dia-
betes and diabetes-related complications through the 
National Diabetes Education Program. 
‘‘(c) DIABETES; HEALTH PROMOTION, PREVENTION 
ACTIVITIES, AND ACCESS.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall carry out culturally 
appropriate diabetes health promotion and preven-
tion programs for minority populations. 
‘‘(2) CERTAIN
ACTIVITIES.—Activities regard-
ing culturally appropriate diabetes health promotion 
and prevention programs for minority populations 
shall include the following: 
‘‘(A) Expanding the Diabetes Prevention 
and Control Program (currently existing in all 
the States and territories) and providing funds 
for education and community outreach on dia-
betes. 
‘‘(B) Providing funds for an expansion of 
the Diabetes Prevention Program Initiative that 
focuses on physical inactivity and diet and its 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00347
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
348 
relation to type 2 diabetes within such popu-
lations. 
‘‘(C) Providing funds to strengthen exist-
ing surveillance systems to improve the quality, 
accuracy, and timeliness of morbidity and mor-
tality diabetes data for such populations. 
‘‘(d) DEFINITION.—For purposes of this section, the 
term ‘minority population’ means a racial and ethnic mi-
nority group, as defined in section 1707. 
‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated such sums as are necessary for fiscal 
year 2010 and each subsequent fiscal year.’’. 
Subtitle C—HEALTH RESOURCES 
AND SERVICES ADMINISTRA-
TION 
SEC. 631. RESEARCH, EDUCATION, AND OTHER ACTIVITIES. 
Part P of title III of the Public Health Service Act, 
as amended, is amended by adding at the end the following 
new section: 
‘‘SEC. 399V. PROGRAMS TO EDUCATE HEALTH PROVIDERS 
ON THE CAUSES AND EFFECTS OF DIABETES 
IN MINORITY POPULATIONS. 
‘‘(a) IN GENERAL.—The Secretary, acting through 
the Director of the Health Resources and Services Admin-
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00348
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
349 
istration, shall conduct and support programs described 
in subsection (b) to educate health professionals on the 
causes and effects of diabetes in minority populations. 
‘‘(b) PROGRAMS.—Programs described in this sub-
section, with respect to education on diabetes in minority 
populations, shall include the following: 
‘‘(1) Making grants for diabetes-focused edu-
cation classes or training programs on cultural sen-
sitivity and patient care within such populations for 
health care providers. 
‘‘(2) Providing funds to community health cen-
ters for programs that provide diabetes services and 
screenings. 
‘‘(3) Providing additional funds for the Health 
Careers Opportunity Program, Centers for Excel-
lence, and the Minority Faculty Fellowship Program 
to partner with the Office of Minority Health under 
section 1707 and the National Institutes of Health 
to strengthen programs for career opportunities 
within minority populations focused on diabetes 
treatment and care. 
‘‘(4) Developing a diabetes focus within, and 
providing additional funds for, the National Health 
Service Corps Scholarship program to place individ-
uals in areas that are disproportionately affected by 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00349
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
350 
diabetes and to provide health care services to such 
areas. 
‘‘(5) Establishing a diabetes ambassador pro-
gram for recruitment efforts to increase the number 
of underrepresented minorities currently serving in 
student, faculty, or administrative positions in insti-
tutions of higher learning, hospitals, and community 
health centers. 
‘‘(6) Establishing a loan repayment program 
that focuses on diabetes care and prevention in mi-
nority populations.’’. 
Subtitle D—ADDITIONAL 
PROGRAMS 
SEC. 641. RESEARCH, EDUCATION, AND OTHER ACTIVITIES. 
Part P of title III of the Public Health Service Act 
(42 U.S.C. 280g et seq.), as amended, is further amended 
by adding at the end the following section: 
‘‘SEC. 399W. RESEARCH, EDUCATION, AND OTHER ACTIVI-
TIES REGARDING DIABETES IN MINORITY 
POPULATIONS. 
‘‘(a) RESEARCH AND OTHER ACTIVITIES.— 
‘‘(1) IN
GENERAL.—In addition to activities 
under sections 317U and 434B, the Secretary shall 
conduct and support research and other activities 
with respect to diabetes within minority populations. 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00350
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
351 
‘‘(2) CERTAIN
ACTIVITIES.—Activities under 
paragraph (1) regarding diabetes in minority popu-
lations shall include the following: 
‘‘(A) Through the National Center on Mi-
nority Health and Health Disparities, the Office 
of Minority Health under section 1707, the 
Health Resources and Services Administration, 
the Centers for Disease Control and Prevention, 
and the Indian Health Service, establishing 
partnerships within minority populations to 
conduct studies on cultural, familial, and social 
factors that may influence health promotion, di-
abetes management, and prevention. 
‘‘(B) Through the Indian Health Service, 
in collaboration with other appropriate Federal 
agencies, coordinating the collection of data on 
ethnic and culturally appropriate diabetes treat-
ment, care, prevention, and services by health 
care professionals to the American Indian popu-
lation. 
‘‘(3) PROGRAMS
RELATING
TO
CLINICAL
RE-
SEARCH.— 
‘‘(A) EDUCATION
REGARDING
CLINICAL 
TRIALS.—The Secretary shall carry out edu-
cation and awareness programs designed to in-
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00351
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
352 
crease participation of minority populations in 
clinical trials. 
‘‘(B) MINORITY RESEARCHERS.—The Sec-
retary shall carry out mentorship programs for 
minority researchers who are conducting or in-
tend to conduct research on diabetes in minor-
ity populations. 
‘‘(C) 
SUPPLEMENTING
CLINICAL
RE-
SEARCH
REGARDING
CHILDREN.—The Sec-
retary shall make grants to supplement clinical 
research programs to assist such programs in 
obtaining the services of health professionals 
and other resources to provide specialized care 
for children with type 1 and type 2 diabetes. 
‘‘(4) ADDITIONAL PROGRAMS.—Activities under 
paragraph (1) regarding education on diabetes in 
minority populations shall include providing funds 
for new and existing diabetes-focused education 
grants and programs for present and future stu-
dents and clinicians in the medical field from minor-
ity populations, including for the following: 
‘‘(A) For Federal and State loan repay-
ment programs for health profession students 
within communities of color. 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00352
Fmt 6652
Sfmt 6201
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS
353 
‘‘(B) For the Office of Minority Health 
under section 1707 for training health profes-
sion students to focus on diabetes within such 
populations. 
‘‘(C) For State and local entities to estab-
lish diabetes awareness week or day every 
month in schools, nursing homes, and colleges 
through partnerships with the Office of Minor-
ity Health under section 1707 and the Health 
Resources and Services Administration. 
‘‘(b) DEFINITION.—For purposes of this section, the 
term ‘minority population’ means a racial and ethnic mi-
nority group as defined in section 1707. 
‘‘(c) AUTHORIZATION OF APPROPRIATIONS.—For the 
purpose of carrying out this section, there are authorized 
to be appropriated such sums as are necessary for fiscal 
year 2010 and each subsequent fiscal year.’’. 
Æ 
VerDate Nov 24 2008 
01:55 Jul 02, 2009
Jkt 079200
PO 00000
Frm 00353
Fmt 6652
Sfmt 6301
E:\BILLS\H3090.IH
H3090
pwalker on DSK8KYBLC1PROD with BILLS